GENERAL COMMENTS I am very thankful being able to review this well designer feasibility trial with a nested qualitative study. Compliments to the authors for the design of the study.
Introduction.
In the introduction you mention the possible altered muscle patterns as the argument to tailor treatment. It might be good to mention the common altered muscle patterns in the introduction. I can see the patterns in the choices of your exercises in the supplementary materials but it would be relevant to mention these earlier.
Last sentence of the introduction should be: "in Table 1 " instead of "on Table 1" Method.
P6 Inclusion criteria:
Following the BESS guidelines in finding the patients with mechanical shoulder pain is a good and standardized way of selecting patients. The choice of the painful arc movement and jobe"s test are indeed mentioned in the BESS guideline. The pain on resisted lateral rotation is not. Where does this test come from? Are these also the tests with the highest positive likelihood ratio?
P6 Recruitment: Which local community?
P6 Sample size:
Where does the expected effect size (0.3 to 0.7) come from?
P6 Informed consent: Demographic data were measured at baseline. Report which demographic data were measured.
P7 Interventions:
Why not do a follow-up until there is a reason for referral which had also been stated in the BESS guideline? The reason being no recovery after 12 weeks of conservative therapy. "Physiotherapy rehabilitation is usually for 6 weeks unless patients are unable to tolerate the exercises, or physiotherapists identify a reason for earlier referral to secondary care. If there is patient improvement in the first 6 weeks of physio" Discussion. P16 : The abstract describes a discussion but the main text does not contain a discussion.
Response: thank you for your comment. We have revised the introduction based on your suggestions.
The other main concern is the design of the study, the authors seem to mix the terms feasibility-, pilot study and protocol publication. Usually, a protocol is published after a pilotstudy, for a full scale RCT.
Response: thank you for your comments. We have revised the text, and used the term feasibility throughout the text.
The present submission is the protocol for a feasibility trial. Other authors have used a similar approach, and published the protocol for the feasibility trial (e.g.
https://bmjopen.bmj.com/content/9/3/e023526, https://bmjopen.bmj.com/content/7/6/e017376, and https://bmjopen.bmj.com/content/6/3/e010574).
The title of the article is: The effectiveness of a tailored rehabilitation versus standard strengthening programme for patients with shoulder pain: a protocol for a feasibility randomized controlled trial (the Otago MASTER trial). The use of the term feasibility trial does not seem adequate here. Normally, a feasibility trial would include about ten participants, where the aim is to test, for example the intervention. Therefore, there is no randomization or control group in such trials. The next phase would be a pilot study, were the aim is to test randomization, blinding etc., and to calculate an appropriate sample size. Response: we are aware there are different definitions for referring to feasibility and pilot studies1-5. In the "CONSORT 2010 statement: extension to randomised pilot and feasibility trials", the authors discuss about the different definitions used by the research community, and they decided to adopt an overarching definition of feasibility trial, with pilot trial being a subset of "feasibility study"3. This is supported by another publication2, where Eldridge et al.2 define pilot studies as a subset of feasibility studies. For the purpose of our study, we followed this definition and we believe this is in agreement with the "CONSORT statement: extension to randomized pilot and feasibility trial"3. Response: Thank you for your comment.
We have removed the statement that refers to a linear relationship between baseline clinical impairment and the course of the disorder.
There is a limited number of head-to-head trials, comparing two active interventions, with one arm using an impairment-based approach to inform decision intervention. Hence, our feasibility trial is still relevant. We believe that our study will be well-placed to address this, and identify clinically significant differences between the two arms (should a real difference exist).
I also find the statement Interventions including sustained glides have been shown to be superior to standard treatment approaches in other musculoskeletal conditions, with reference to a RCT on tennis elbow, disturbing.
Response: We revised the text to be more explicitly about that study. We are referring to a trial published by BMJ that compared mobilization with movement and exercise to corticosteroid injection and wait-and-see. We used this statement to illustrate that a "multimodal intervention" using MWM was used before and proved to be more effective than corticosteroid injection and wait-and-see.
Page 4, Line 41 the authors introduce the term standard exercises. In our view, there is no such standard. I think clinicians within shoulder rehabilitation would oppose the idea of one size fits all. Instead, the idea of targeting interventions to impaired movement functions in the shoulder, has been one of the basic ideas in exercise treatment for years.
Response: thank you for your comment. We have revised the term "standard" and replaced with "standardized". In our study, the term "standardized" exercise refers to a series of strengthening and stretching exercises that may be adapted, in a standardized (that is, a protocol defined) way, once patients are exposed to the "core exercises". This intervention was based on a previous trial that found the exercise programme to be effective to improving clinical outcomes in patients with shoulder subacromial pain.
Page 7, Line 14: The inclusion criteria should be worked through; the present criteria without doubt also will include patients with a number of other shoulder disorders, including Adhesive Capsulitis.
Response: thank you for your comment. The exclusion criteria have been revised to enhance clarity. We followed the BESS guidelines, and through this, participants are excluded if they present signs of adhesive capsulitis. Table 2 provides an overview of the targeted intervention. One of my many concerns with this treatment would be that the targeting will be tailored based on so-called physical assessment, without any validated measure. Although a number of impairment tests are mentioned, the reliability of these, at the best are doubtful.
Response: thank you for your comment. We are aware there is debate on the utility of the so-called "physical assessment", yet, a number of clinicians and researchers use this or a similar rationale for treating patients with shoulder pain.6-9 Hence, we believe our trial addresses an important research question and will add value to current literature.
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Please leave your comments for the authors below I am very thankful being able to review this well designer feasibility trial with a nested qualitative study. Compliments to the authors for the design of the study.
Response: thank you. We have revised the introduction to address that.
Last sentence of the introduction should be: "in Table 1 " instead of "on Table 1 " Response: revised.
Method.
P6 Inclusion criteria:
Response: thank you for your comment. We have revised the text to clarify this.
Given the limited evidence of clinical tests for assessing patients with shoulder subacromial pain, we opted to widen our inclusion criteria and include two additional tests (resisted lateral rotation and shoulder abduction).10 Pain on external rotation has been reported to have 34.5% sensitivity, 100% specificity, 42% accuracy; pain on shoulder abduction has been reported to have 55% of sensitivity, 75% specificity, 57% accuracy and a likelihood ratio of 2.2%; and pain on external rotation was the most accurate test for identifying partialthickness tears. 10 
P6 Informed consent:
Demographic data were measured at baseline. Report which demographic data were measured. Response: revised.
P7 Interventions:
Why not do a follow-up until there is a reason for referral which had also been stated in the BESS guideline? The reason being no recovery after 12 weeks of conservative therapy. "Physiotherapy rehabilitation is usually for 6 weeks unless patients are unable to tolerate the exercises, or physiotherapists identify a reason for earlier referral to secondary care. If there is patient improvement in the first 6 weeks of physio"
Response: That is a good point. We did not follow the BESS guidelines, since this trial does not represent "usual care" practice. We deemed appropriate to expose patients to a longer intervention period. Another trial suggested the need for 8 weeks of intervention when managing patients with shoulder subacromial pain.12 Another study also reports that it is unclear how long exercises should be performed for, and they suggest a minimum of 12 weeks. Given the lack of evidence in this area, we opted for 8 weeks, following suggestions from Wang et al.12
Discussion.
P16 : The abstract describes a discussion but the main text does not contain a discussion. Response: thank you for your comment. We have added a discussion section in the main text. Introduction Aims 6 and 7; consider to drop these aims. The design of the feasibility study imply that no conclusions of treatment effects should be drawn. Also consider to leave out aim#5 reading "adverse reactions to treatmen"; what is this, adverse events?. Instead of these three aims, I would suggest an aim referring to the acceptability of the intervention (ref consort statements).
Methods
The sentence reading "The Management of subacromial disorders of the shoulder (MASTER) trial, is a twoarm, patient-and assessorblinded, randomized controlled feasibility trial" needs to be revised because I think it may contain a confusing mix of terms. Although I am aware that feasibility trials are used differently in the literature, I find the term "randomized controlled feasibility trial", confusing.
Specific comments: P3. Line 50: "however, high quality longitudinal studies are still required to clarify the influence of psychological factors on disability and pain in patients with shoulder suabcromial disorders". Consider rephrasing this sentence. The study by Chester et al provides high quality evidence for this. P4 Consider removing/deleting the paragraph Lines 24-32 because it points at the aim of the study, rather than showing a knowledge gap that this study might fill.
P7 Line 30 "participants with symptoms of inflammation or systematic disease,". This exclusion criteria should be more specified; all kinds of systemic disease and inflamation?
P7 Line 57 "…and newspaper advertisements". These should not be considered patients, because they rather volunteer for a study, rather than seeking health care. The use of advertisements need to be justified.
P8 Line 29 Will any workshop or other kind of training for the trating physiotherapists be provided? Please elaborate.
P14 Line 54: The primary outcome measures should be those planned in the main RCT-study, this id the SPADI and the PSFS, right? As it reads now, it"s rather confusing. The aims of the present study do not refer to the outcome measures.
P16 Line 17 "We will use a linear mixed-effect model to obtain estimates of intervention effects, we will compare changes in pain and shoulder-related disability scores between the two intervention groups (i.e. tailored and standardized rehabilitation)." You should not conduct any analyses referring to treatment effects on this study. The effectiveness does not refer to any of the study aims! P19 Line 3: I do not agree that the risk of adverse events are minimal. Based on previous research on exercise interventions, adverse events are frequent, but often not serious. Thus, a systematic assessment of adverse events should definitely be implemented in the trial.
VERSION 2 -AUTHOR RESPONSE
Reviewer(s)' Comments to Author:
Reviewer: 1
Reviewer Name: Yngve Roe Institution and Country: OsloMet -Oslo Metropolitan University, Norway Please state any competing interests or state "None declared": None declared
Please leave your comments for the authors below Introduction Aims 6 and 7; consider to drop these aims. The design of the feasibility study imply that no conclusions of treatment effects should be drawn.
Response: thank you for your comment. We have re-worded aims #6 and #7 to clarify this. We do not aim to make conclusions about treatment effects, but we do aim to obtain exploratory estimates for these outcomes. This is suggested in the literature as an element of pilot and feasibility trials [1] [2] [3] [4] [5] and is included in the CONSORT statement for feasibility trials [6] . For that reason, we opted to maintain aims #6 and #7. These recommendations [1] [2] [3] [4] [5] have been adopted by a number of previous feasibility and pilot trials published in BMJ Open or similar journals [7] [8] [9] .
Also consider to leave out aim#5 reading "adverse reactions to treatment"; what is this, adverse events?. Instead of these three aims, I would suggest an aim referring to the acceptability of the intervention (ref consort statements).
Response: Thank you for your suggestion. We have re-worded it as "adverse events" and decided to include it in the protocol. We understand that assessing acceptability of an intervention might be achieved through a number of methods (e.g. adverse events, clinicians" and patients" perceptions on the intervention). We preferred to be more specific and assess exploratory estimates of adverse events.
Methods
The sentence reading "The Management of subacromial disorders of the shoulder (MASTER) trial, is a twoarm, patient-and assessor-blinded, randomized controlled feasibility trial" needs to be revised because I think it may contain a confusing mix of terms. Although I am aware that feasibility trials are used differently in the literature, I find the term "randomized controlled feasibility trial", confusing.
Response: Thank you for your suggestion. We re-ordered the words on the title (using an example described on CONSORT). It now reads:
"The Management of subacromial disorders of the shoulder (MASTER) trial, is a two-arm, patient-and assessor-blinded, feasibility randomized controlled trial. Patients will be randomly allocated into one of the interventions group: tailored rehabilitation or standardized rehabilitation"
Specific comments:
P3. Line 50: "however, high quality longitudinal studies are still required to clarify the influence of psychological factors on disability and pain in patients with shoulder suabcromial disorders". Consider rephrasing this sentence. The study by Chester et al provides high quality evidence for this.
Response: Thank you for your suggestion.
We have revised the text. It now reads:
"Further longitudinal studies are still required to clarify which psychological factors can be targeted by treatment and whether modifying these psychological factors impact on clinical outcomes (i.e. disability and pain) in patients with shoulder subacromial disorders. [10] [11] [12] [13] ." Response: Thank you for your comment. We have revised the text, and added a paragraph prior to the paragraph originally starting at line 54. We have added additional references to support statements.
P4 Consider removing/deleting the paragraph Lines 24-32 because it points at the aim of the study, rather than showing a knowledge gap that this study might fill.
Response: thank you for your suggestion. We have re-worded this paragraph, so it does not read as the aim of the study, and it presents a knowledge gap.
Response: thank you. We have revised the text.
Response: thank you for your comment. We have revised the text, and replaced patients with participants. We have added a sentence justifying our method for recruiting participants.
It reads: "In previous studies, we have successfully recruited participants with these methods of recruitment."
Response: thank you for your comment. We have added a paragraph explaining this further.
It reads: "We will run a minimum of 4 training sessions lasting for one hour with clinicians to ensure they are familiarized with the protocol. To ensure they are confident in delivering the planned interventions, we will provide them with manuals containing a detailed description of the planned intervention and will meet with them during the study to clarify any questions or concerns that may arise." P14 Line 54: The primary outcome measures should be those planned in the main RCT-study, this id the SPADI and the PSFS, right? As it reads now, it"s rather confusing. The aims of the present study do not refer to the outcome measures.
Response: Thank you for your comment. Our primary outcome measures are those related to the feasibility aims (i.e. (1) participant recruitment rate; (2) the proportion of participants enrolled from the total number screened; (3) adherence to the rehabilitation programme; (4) drop-out rates).
This is in line with recommendations from the literature, [1] and CONSORT statement for feasibility trials. [6] In addition, previous feasibility trials published in BMJ Open have adopted a similar approach. [8] To enhance clarity, we have revised the "secondary outcome measure" section, and added a sentence stating that "Findings from this feasibility trial will help us selecting the primary outcome measure for the full trial.
[1]" P16 Line 17 "We will use a linear mixed-effect model to obtain estimates of intervention effects, we will compare changes in pain and shoulder-related disability scores between the two intervention groups (i.e. tailored and standardized rehabilitation)." You should not conduct any analyses referring to treatment effects on this study. The effectiveness does not refer to any of the study aims!
